# US 2019/0314058 A1 · Tissue interface apparatus, systems, and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0314058 A1
- Document ID: US20190314058A1
- Status: Published application
- Kind: A1
- Application number: 16/380,338
- Filed: 2019-04-10
- Published: 2019-10-17
- Earliest claimed: 2018-04-11
- Assignees: Vadovations, Inc.
- Applicants: VADovations, Inc.
- Inventors: J. Ryan Stanfield; James W. Long; Michael A. Vladovich
- Web page: https://patentgrep.com/patent/US20190314058A1

## CPC

- A61B 17/3423: {Access ports, e.g. toroid shape introducers for instruments or hands (access sites for liquids A61M39/0247)}
- A61B 17/00234: {for minimally invasive surgery (A61B17/0218, A61B17/0469, A61B17/12013, A61B17/1285, A61B17/29, A61B17/320016 take precedence)}
- A61B 17/3468: {for implanting or removing devices, e.g. prostheses, implants, seeds, wires (devices for implanting seeds A61M37/0069)}
- A61B 17/3496: {Protecting sleeves or inner probes; Retractable tips (for protecting body piercing guide needles A61M25/0612)}
- A61B 2017/00243: {cardiac}
- A61B 2017/00849: {with respect to tissue, e.g. hollow organs}
- A61B 2017/00867: {shape memory effect}
- A61B 2017/3425: {for internal organs, e.g. heart ports}
- A61B 2017/3435: {using everted sleeves}
- A61B 2017/348: {Means for supporting the trocar against the body or retaining the trocar inside the body}
- A61B 2017/3484: {Anchoring means, e.g. spreading-out umbrella-like structure}
- A61B 2017/3488: {Fixation to inner organ or inner body tissue}
- A61M 2210/125: Heart
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

In an aspect, a device includes a body structure including a core and a sleeve disposed around at least a portion of the core, the core defining a channel through the core extending from a first end of the core to a second end of the core, the sleeve including a flange adjacent the second end of the core; and a deployable portion coupled to the body structure adjacent the first end of the core, the deployable portion having a wired structure transitionable between a retained configuration and a deployed configuration, wherein a top portion of the wired structure extends beyond the first end of the core in a longitudinal direction when the wired structure is in the retained configuration, and wherein first end of the core extends beyond the top portion of the wired structure when the wired structure is in the deployed configuration.

## Claims

### Claim 1

A biologic tissue interface device comprising:
a body structure including a core and a sleeve disposed around at least a portion of the core, the core defining a channel through the core extending from a first end of the core to a second end of the core, the sleeve including a flange adjacent the second end of the core; and
a deployable portion coupled to the body structure adjacent the first end of the core, the deployable portion having a wired structure transitionable between a retained configuration and a deployed configuration, wherein a top portion of the wired structure extends beyond the first end of the core in a longitudinal direction from the first end of the core to the second end of the core when the wired structure is in the retained configuration, and wherein the first end of the core extends beyond the top portion of the wired structure when the wired structure is in the deployed configuration.

### Claim 2 (depends on 1)

The biologic tissue interface device of claim 1, wherein the wired structure is formed from at least one of nitinol, stainless steel, cobalt chromium, or alloys thereof.

### Claim 3 (depends on 1)

The biologic tissue interface device of claim 1, wherein an end point of the wired structure of the deployable portion is coupled to an exterior surface of the sleeve.

### Claim 4 (depends on 1)

The biologic tissue interface device of claim 1, wherein an end point of the wired structure of the deployable portion is coupled to an interior surface of the core, the interior surface defining the channel.

### Claim 5 (depends on 4)

The biologic tissue interface device of claim 4, wherein the core defines a plurality of channels into which at least a portion of the wired structure fits when the wired structure is in the deployed configuration.

### Claim 6 (depends on 4)

The biologic tissue interface device of claim 4, wherein the end point of the wired structure is coupled to the interior surface of the core via a rotatable connector about which the wired structure rotates during transition between the retained configuration and the deployed configuration.

### Claim 7 (depends on 1)

The biologic tissue interface device of claim 1, wherein the core includes a first flange adjacent the first end and a second flange adjacent the second end, and wherein the sleeve is coupled between the first flange and the second flange.

### Claim 8 (depends on 1)

The biologic tissue interface device of claim 1, wherein the sleeve includes a fibrous material.

### Claim 9 (depends on 1)

The biologic tissue interface device of claim 1, wherein the sleeve includes at least one of a polytetrafluoroethylene (PTFE) felt, polyethylene terephthalate (PET), or bovine pericardium.

### Claim 10 (depends on 1)

The biologic tissue interface device of claim 1, wherein the deployable portion includes a fibrous material coupled to the wired structure.

### Claim 11 (depends on 1)

The biologic tissue interface device of claim 1, wherein the deployable portion includes at least one of a polytetrafluoroethylene (PTFE) felt, polyethylene terephthalate (PET), or bovine pericardium coupled to the wired structure.

### Claim 12 (depends on 1)

The biologic tissue interface device of claim 1, further including a hemostatic valve seal coupled to the core and covering the channel with a plurality of flexible members.

### Claim 13 (depends on 1)

The biologic tissue interface device of claim 1, further including second deployable portion coupled to the core adjacent the second end of the core.

### Claim 14

A biologic tissue interface device comprising:
a body structure including a core and a sleeve disposed around at least a portion of the core, the core defining a channel through the core extending from a first end of the core to a second end of the core, the body structure defining a first vertical perimeter extending longitudinally from an interior surface of the core in a direction from the second end of the core to the first end of the core and a second vertical perimeter extending longitudinally from an exterior surface of the body portion in a direction from the second end of the core to the first end of the core, the sleeve including a flange adjacent the second end of the core; and
a deployable portion coupled to the body structure adjacent the first end of the core, the deployable portion having a wired structure transitionable between a retained configuration and a deployed configuration, wherein an end portion of the deployable portion is held within the first vertical perimeter when the wired structure is in the retained configuration, and wherein the end portion of the deployable portion extends beyond the second vertical perimeter in a direction from the channel to the exterior surface of the body portion when the wired structure is in the deployed configuration.

### Claim 15 (depends on 14)

The biologic tissue interface device of claim 14, wherein the wired structure is formed from at least one of nitinol, stainless steel, cobalt chromium, or alloys thereof.

### Claim 16 (depends on 14)

The biologic tissue interface device of claim 14, wherein an end point of the wired structure of the deployable portion is coupled to the exterior surface of the body portion.

### Claim 17 (depends on 14)

The biologic tissue interface device of claim 14, wherein an end point of the wired structure of the deployable portion is coupled to an interior surface of the core, the interior surface defining the channel.

### Claim 18 (depends on 17)

The biologic tissue interface device of claim 17, wherein the core defines a plurality of channels into which at least a portion of the wired structure fits when the wired structure is in the deployed configuration.

### Claim 19 (depends on 14)

The biologic tissue interface device of claim 14, wherein the core includes a first flange adjacent the first end and a second flange adjacent the second end, and wherein the sleeve is coupled between the first flange and the second flange.

### Claim 20 (depends on 14)

The biologic tissue interface device of claim 14, wherein at least one of the sleeve and the deployable portion includes a fibrous material.
